STOCK TITAN

Arteris, Inc. SEC Filings

AIP NASDAQ

Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading Arteris, Inc.'s SEC filings can feel like navigating a dense wiring diagram—hundreds of pages on deferred royalties, automotive safety certifications, and stock-based compensation. If you need the revenue backlog buried in a 10-K or want to spot Form 4 trades before the next design-win press release, the traditional EDGAR search simply takes too long.

Stock Titan solves this problem. Our AI-powered summaries translate complex semiconductor accounting into plain language, flagging key metrics such as licensing revenue mix, R&D capitalization trends, and customer concentration. Real-time alerts pull every Arteris quarterly earnings report 10-Q filing, 8-K material events explained in minutes, and Arteris insider trading Form 4 transactions as they post—so you never miss a disclosure.

Here’s what you can uncover instantly:

  • Arteris annual report 10-K simplified—royalty schedules, risk factors, and segment performance distilled within seconds.
  • Arteris Form 4 insider transactions real-time—track executive stock sales or option exercises alongside AI context on upcoming product milestones.
  • Proxy statement executive compensation—see how design-win milestones affect equity awards without combing through tables.
  • Arteris earnings report filing analysis—compare quarter-over-quarter gross margin shifts and R&D intensity.

Whether you’re monitoring executive stock transactions, assessing patent litigation exposure, or just trying to understand Arteris SEC filings explained simply, our platform surfaces the data professionals rely on—no jargon, no delays.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
current report
Rhea-AI Summary

Insider sale reported by Arteris VP & CFO Nicholas B. Hawkins on Form 4.

  • Transaction date: 08/01/2025.
  • Shares sold: 5,638 common shares (reported as Direct disposition).
  • Weighted-average sale price: $9.0328; reported range: $9.00 to $9.27.
  • Sale executed pursuant to a 10b5-1 trading plan adopted May 20, 2024.
  • Shares beneficially owned after the transaction: 119,272 (Direct).
  • Form signed by attorney-in-fact Paul Alpern on 08/04/2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Arteris (AIP)?

The current stock price of Arteris (AIP) is $9.78 as of August 25, 2025.

What is the market cap of Arteris (AIP)?

The market cap of Arteris (AIP) is approximately 425.2M.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Stock Data

425.22M
29.50M
30.79%
47.8%
2.57%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL